Genocea Biosciences Inc. (GNCA)

0.93
NASDAQ : Health Technology
Prev Close 0.99
Day Low/High 0.90 / 1.00
52 Wk Low/High 0.79 / 6.78
Avg Volume 623.70K
Exchange NASDAQ
Shares Outstanding 86.58M
Market Cap 85.70M
EPS -2.00
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

NEA Partner Ali Behbahani, M.D. Joins Genocea Biosciences' Board Of Directors

NEA Partner Ali Behbahani, M.D. Joins Genocea Biosciences' Board Of Directors

Follows NEA investment in Genocea during January 2018 concurrent equity financings

Short Interest In Genocea Biosciences Drops 31.7%

Short Interest In Genocea Biosciences Drops 31.7%

The most recent short interest data has been released for the 12/29/2017 settlement date, which shows a 689,309 share decrease in total short interest for Genocea Biosciences Inc , to 1,488,114, a decrease of 31.66% since 12/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

GENOCEA LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $500,000 In Genocea Biosciences, Inc. To Contact The Firm

GENOCEA LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $500,000 In Genocea Biosciences, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Genocea Biosciences, Inc.

Scott+Scott, Attorneys At Law, LLP Reminds Investors That The Lead Plaintiff Deadline In Genocea Biosciences, Inc. (GNCA) Class Action Is January 2nd

Scott+Scott, Attorneys At Law, LLP Reminds Investors That The Lead Plaintiff Deadline In Genocea Biosciences, Inc. (GNCA) Class Action Is January 2nd

Scott+Scott, Attorneys at Law, LLP ("Scott+Scott"), a national securities and consumer rights litigation firm, is reminding investors that a class action has been filed against Genocea Biosciences, Inc.

Scott+Scott, Attorneys At Law, LLP Filed Class Action Against Genocea Biosciences, Inc. (GNCA) - Lead Plaintiff Deadline Is January 2nd

Scott+Scott, Attorneys At Law, LLP Filed Class Action Against Genocea Biosciences, Inc. (GNCA) - Lead Plaintiff Deadline Is January 2nd

Scott+Scott, Attorneys at Law, LLP ("Scott+Scott"), a national securities and consumer rights litigation firm, has filed a class action against Genocea Biosciences, Inc.

DEADLINE ALERT: Brower Piven Reminds Investors Of Upcoming Deadline In Class Action Lawsuit And Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Genocea Bioscience, Inc. To Contact The Firm

DEADLINE ALERT: Brower Piven Reminds Investors Of Upcoming Deadline In Class Action Lawsuit And Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Genocea Bioscience, Inc. To Contact The Firm

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of Massachusetts on behalf of...

The Klein Law Firm Reminds Investors Of A Class Action Filed On Behalf Of Genocea Biosciences, Inc. Shareholders And A Lead Plaintiff Deadline Of January 2, 2018

The Klein Law Firm Reminds Investors Of A Class Action Filed On Behalf Of Genocea Biosciences, Inc. Shareholders And A Lead Plaintiff Deadline Of January 2, 2018

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Genocea Biosciences, Inc.

Glancy Prongay & Murray LLP Commences Investigation On Behalf Of Genocea Biosciences, Inc. Investors (GNCA)

Glancy Prongay & Murray LLP Commences Investigation On Behalf Of Genocea Biosciences, Inc. Investors (GNCA)

Glancy Prongay & Murray LLP ("GPM") announces an investigation on behalf of Genocea Biosciences, Inc.

GNCA INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Genocea Biosciences, Inc. And A Lead Plaintiff Deadline Of January 2, 2018

GNCA INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Genocea Biosciences, Inc. And A Lead Plaintiff Deadline Of January 2, 2018

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the U.

EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Genocea Biosciences, Inc. Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of January 2, 2018

EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Genocea Biosciences, Inc. Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of January 2, 2018

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Genocea Biosciences, Inc.

The Klein Law Firm Announces A Class Action Filed On Behalf Of Genocea Biosciences, Inc. Shareholders And A Lead Plaintiff Deadline Of January 2, 2018

The Klein Law Firm Announces A Class Action Filed On Behalf Of Genocea Biosciences, Inc. Shareholders And A Lead Plaintiff Deadline Of January 2, 2018

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Genocea Biosciences, Inc.

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Genocea Bioscience, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Genocea Bioscience, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of Massachusetts on behalf of...

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Genocea Biosciences, Inc. Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of January 2, 2018

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Genocea Biosciences, Inc. Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of January 2, 2018

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Genocea Biosciences, Inc.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Genocea Biosciences, Inc. - GNCA

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Genocea Biosciences, Inc. - GNCA

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Genocea Biosciences, Inc.

The Klein Law Firm Reminds Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Genocea Biosciences, Inc. (GNCA)

The Klein Law Firm Reminds Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Genocea Biosciences, Inc. (GNCA)

The Klein Law Firm reminds investors of the commencement of an investigation of Genocea Biosciences, Inc.

The Klein Law Firm Notifies Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Genocea Biosciences, Inc.

The Klein Law Firm Notifies Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Genocea Biosciences, Inc.

The Klein Law Firm announces the commencement of an investigation of Genocea Biosciences, Inc.

GNCA INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Genocea Biosciences, Inc.

GNCA INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Genocea Biosciences, Inc.

The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Genocea Biosciences, Inc.

GNCA SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Genocea Biosciences, Inc.

GNCA SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Genocea Biosciences, Inc.

The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Genocea Biosciences, Inc.